Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
5.13
+0.03 (0.59%)
At close: Oct 2, 2026, 4:00 PM EDT
5.20
+0.07 (1.36%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $411.45 million as of October 2, 2026. Its market cap has increased by 80.03% in one year.
Market Cap
411.45M
Enterprise Value
192.41M
1-Year Change
80.03%
Ranking
Category
Stock Price
$5.13
ChartMarket Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $411.45M, a decrease of -78.77%. That is a compound annual growth rate of -23.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 411.45M | 47.52% |
| Dec 31, 2025 | 278.91M | -1.43% |
| Dec 31, 2024 | 282.95M | 11.19% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tectonic Therapeutic | 440.64M |
| Prothena Corporation | 429.18M |
| AgomAb Therapeutics NV | 421.56M |
| Rezolute | 420.64M |
| ARS Pharmaceuticals | 404.75M |
| Editas Medicine | 402.38M |
| Turn Therapeutics | 397.07M |
| Eikon Therapeutics | 397.03M |